Official Publications Novartis AG

Equities

Real-time Estimate Cboe Europe Other stock markets 10:52:27 2025-12-05 am EST			5-day change	1st Jan Change
107.01 ^CHF	+0.12%		+2.47%	+20.70%

11:40pm	Lupin Gets Tentative U.S. FDA Nod for Siponimod Tablets	MT
Dec. 03	Sector Update: Health Care Stocks Higher Late Afternoon	MT

Nov. 12	Director/PDMR/Person closely associated - Disposal/Sale	CO
Nov. 06	Director/PDMR/Person closely associated - Disposal/Sale	CO
Oct. 27	Slide show Q3	CO
Oct. 27	3rd quarter results	CO
Oct. 27	3rd quarter results	CO
Oct. 27	3rd quarter report	CO
Sep. 15	Director/PDMR/Person closely associated - Disposal/Sale	CO
Jul. 16	Slide show half-year results	CO
Jul. 16	1st-half-year results	CO
Jul. 16	Half-yearly ESG report	CO
Jul. 16	Half-year report	CO
Jul. 16	1st-half-year results	CO
Jun. 18	Director/PDMR/Person closely associated - Disposal/Sale	CO
Jun. 02	Director/PDMR/Person closely associated - Disposal/Sale	CO
May. 22	Director/PDMR/Person closely associated - Disposal/Sale	CO
Apr. 28	Slide show Q1	CO
Apr. 28	1st quarter results	CO
Apr. 28	1st quarter results	CO
Apr. 28	ESG Quarterly Report	CO
Apr. 28	1st quarter report	CO
Mar. 06	Shareholders meeting voting results	CO
Mar. 06	Minutes of the general assembly	CO
Mar. 06	Minutes of the general assembly	CO
Jan. 30	SEC Filing 20 F	CO
Jan. 30	Integrated report	CO

NOVARTIS : Q3 largely met expectations; wait for sentiment-driven dips

October 28, 2025 at 11:00 am EDT

Novartis CEO Says They Will Have to 'Tackle Rhetoric' in US Healthcare